One quarter of all breast cancers are among people with triple negative HER2 breast cancer. The aggressive form of cancer is caused by a mutation in cells. Dr. Joshua LaBaer of Arizona State University’s BioDesign Institute and his partner are trying to figure out what is causing those mutations and that would lead to better treatments. Dr. LaBear discusses his work.
